文献速递耳科与耳神经小儿耳鼻咽喉

CDH23 突变相关听力损失儿童的耳蜗植入结局

Cochlear Implantation Outcomes in Children With CDH23 Mutations-Associated Hearing Loss.
PubMed 文献 · Otolaryngol Head Neck Surg · 2021-11-09

回顾性病例复习纳入 2017 至 2019 年本中心 5 例携带 6 个 CDH23 变异、语前极重度感音神经性听力损失儿童,其中 4 个变异为新变异,所有患儿外毛细胞功能丧失、残余听力平均 3 至 10 dB SPL;11 至 36 月龄行耳蜗植入,术后 14 至 120 个月听力和言语表现均获改善。

要点

  • 5 例语前极重度听力损失患儿携带 6 个 CDH23 变异,其中 4 个为新变异。
  • 所有患儿外毛细胞功能丧失,残余听力平均 3 至 10 dB SPL。
  • 11 至 36 月龄行耳蜗植入,术后 14 至 120 个月听力与言语表现改善。

核心结论

  • CDH23 变异所致先天性耳蜗缺陷儿童在耳蜗植入后可获得可接受的听力和言语结局。
  • 作者认为,针对 CDH23 等罕见耳聋基因的早期基因检测和产前咨询仍是未来的优先事项。

研究设计与样本

  • 回顾性病例复习,在三级转诊中心对中国的重度感音神经性听力损失家系进行靶向耳聋相关基因 panel 测序,分析携带潜在致病 CDH23 突变者的临床特征。
  • 2017 至 2019 年在本中心识别 5 例语前极重度听力损失儿童,携带 6 个与疾病共分离的 CDH23 变异。

主要发现

  • 5 例患儿共检出 6 个 CDH23 变异,其中 4 个为新变异(c.2591G>T、c.4785G>C、c.5765A>G 和 c.9280_9281insTT)。
  • 所有受累个体均存在外毛细胞功能丧失,残余听力平均水平为 3 至 10 dB SPL。
  • 患儿在 11 至 36 月龄接受耳蜗植入,术后 14 至 120 个月听力、语言和言语表现均获得改善,听觉结局在随访间期内改善。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mutations in the cadherin 23 gene (CDH23) have been reported to cause cochlear damage, but few studies have investigated the auditory and speech outcome of patients after cochlear implantation. Here, we describe the genetic, auditory, and postoperative outcomes of patients with CDH23 mutations who received cochlear implants. STUDY DESIGN: Retrospective case review. SETTING: Tertiary referral center. METHODS: Targeted deafness-related gene panels were sequenced in Chinese families with profound sensorineural hearing loss. The clinical features of subjects carrying potentially pathogenic CDH23 mutations were analyzed. RESULTS: Between 2017 and 2019, we identified 5 children with prelinguistically profound hearing loss at our center who harbored 6 variants of CDH23 that segregated with the disease. Of these, 4 variants were novel (c.2591G>T, c.4785G>C, c.5765A>G, and c.9280_9281insTT). All affected individuals had a loss of outer hair cell function, with an average residual hearing level of 3 to 10 dB SPL. Cochlear implantations were arranged for the patients at 11 to 36 months of age. All children made gains in their hearing, language, and speech performances 14 to 120 months after surgery. Their auditory outcomes improved during follow-up intervals. CONCLUSION: This study revealed that children with congenital cochlear defects caused by CDH23 variants can acquire an acceptable auditory and speech outcome after cochlear implantation. Early genetic detection and prenatal counseling for rare deafness genes such as CDH23 remain a priority for the future.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Chen K, Huang B, Sun J, et al. Cochlear Implantation Outcomes in Children With CDH23 Mutations-Associated Hearing Loss. Otolaryngol Head Neck Surg. 2021. PMID: 34752165. doi:10.1177/01945998211057427

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。